Join BIOCYTOGEN at 7th SCBA Hepatology Division & CALS Annual Symposium
We are thrilled to announce our participation as an exhibitor at the SCBA Hepatology Division & CALS Annual Symposium 2024. Taking place from November 13th to 14th in San Diego, this prestigious event is a prime gathering of the world’s top experts and innovators in biological science. It provides a unique platform for exchanging groundbreaking ideas, gaining valuable insights, and driving forward new advancements in the field.
As leaders from academia, industry, and research institutions come together, the symposium fosters dynamic collaboration and knowledge-sharing on a global scale. We look forward to engaging with the brightest minds in the field, exploring the latest research trends, and contributing to the discussions that will shape the future of hepatology and biological science. Don’t miss this opportunity to be part of the scientific revolution taking place at this high-profile international event!
What is the SCBA Hepatology Division & CALS Annual Symposium 2024?
The SCBA Hepatology Division & CALS Annual Symposium explores cutting-edge advancements in biological science, bringing together leading researchers who are making significant contributions in their fields. These innovators are driving groundbreaking research while also fostering education by mentoring future scientists.
SCBA plays a vital role in promoting scientific innovation and collaboration, organizing prestigious international conferences that strengthen connections between members and global colleagues. These events serve as platforms for exchanging ideas and advancing research, driving progress in the biological and medical sciences. Through its efforts, SCBA continues to make a lasting impact on science and education worldwide.
Event Overview
Date: November 13th 11:00 am – 14th 03:40 p.m.
Venue: Hilton San Diego Airport/Harbor Island
Event Schedule
The (SCBA) Hepatology Division & CALS Annual Symposium in San Diego will showcase a diverse array of speakers and topics. For a comprehensive look at the daily schedule, including session times and detailed information on each presentation, please refer to the (SCBA) Hepatology Division & CALS Annual Symposium 2024 agenda.
About BIOCYTOGEN
Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company’s sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).
We look forward to seeing you at the (SCBA) Hepatology Division & CALS Annual Symposium 2024 in San Diego!